Genomeminer
Tokyo, JP · Founded 2015 · 5 employees on LinkedIn · 1 known investors
GenomeMiner develops A.I.-driven bioinformatics and genome mining software, using DNA sequencing and proprietary data from organisms in subtropical Okinawa to identify and produce valuable natural products. Originally founded as Tupac.Bio building tools for synthetic biology companies, it aims to serve the biotech industry and eventually develop its own end-products.
Also known as GenomeMiner · Tupac.Bio
Founders & leadership
Genomeminer was founded in 2015 by Eli, Nick, and Justin.
Investors · 1
Company profile
researched Aug 2026GenomeMiner provides a cloud-based bioinformatics platform for processing and managing genomic data. The platform organizes work into project workspaces and lets users run complex analysis pipelines and standalone tools without purchasing high-performance computing hardware or maintaining IT infrastructure. Runtime environments are provisioned on demand for each step of a pipeline, with data passed automatically between steps, and multiple jobs can be executed in parallel.
Platform features include centralized data management with data tables, data tagging and run-history filtering; role- and permission-based access control at the project level; a sequence editor for viewing and editing sequences and creating biodesigns; GenomeViewer for navigating large genomes and visualizing SNPs and variants; an integrated BLAST user interface supporting database management, pasted sequences or multi-record FASTA uploads, sortable results and saved search history; and support for developing AI models on the platform and using them within AI pipelines.
The platform is positioned for a range of users, from individual researchers and small teams to enterprise organizations, with adaptable deployment options intended to integrate with existing infrastructure.
Business model
GenomeMiner sells access to its bioinformatics software platform, combining tiered subscription plans (Basic for single users, Professional for small teams, Enterprise for large organizations) with a pay-as-you-go token system in which pipelines consume tokens so users pay only for the compute resources they use.
Tiered plans differentiated by storage (8GB for Basic, 1TB for Professional, unlimited for Enterprise), team workspace, custom deployment, custom pipelines and pipeline access, plus consumption-based token charges per pipeline run. A free single-user trial provides public-server access, public data only, 100 tokens and 10GB storage; an Enterprise Starter option offers an independent instance, 90-day starter access, three users, unlimited pipeline use and 40GB storage on a contact-us basis.
▸Full profile — market position, technology, go-to-market
Market position
Removes the need for customers to buy an HPC cluster or maintain servers and runtime environments, packaging pipeline automation, data management, BLAST, sequence and genome visualization and AI model development into one workspace-based platform with resource-metered token pricing.
Technology
Cloud-based bioinformatics infrastructure with on-demand server spin-up and per-step runtime environments, automated data hand-off between pipeline steps, and parallel job execution. Analytical and visualization components include a BLAST interface, a DNA and protein sequence viewer and editor, a genome browser with SNP and variant visualization, and facilities for developing and deploying AI models inside pipelines.
Go-to-market
Self-serve entry via a free single-user trial and product demos, alongside a contact-driven enterprise track offering free consultations, custom pipeline consultation, independent instance setup and the option to add tools from GitHub.
Genomics and life-science researchers across scales: individual users, small teams, and enterprise-level organizations that need standardized, collaborative genomic data processing without in-house HPC clusters or IT support.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
▸Research sources · 1
primary sources listed
- Genomeminergenomeminer.ai · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Genomeminer do?
- GenomeMiner offers a cloud bioinformatics platform for automated genomic data processing, pipelines and analysis.
- Who founded Genomeminer?
- Genomeminer was founded by Eli, Nick, Justin in 2015.
- Who are Genomeminer's investors?
- Genomeminer's investors include DG Daiwa Ventures.
- Where is Genomeminer headquartered?
- Genomeminer is headquartered in Tokyo, JP.